Hub: Tech for Good
Stories from Hub: Tech for Good come first, newest first, then stories from connected topics (AI Science & Health, Biotech, AI for science, drug discovery, protein design, Healthcare), each labelled with where it comes from. This view is not indexed by search engines.
Personalised mRNA Therapy Cuts Melanoma Recurrence or Death Risk 42%
In a 1,137-patient phase 3 trial, intismeran plus Keytruda cut the risk of melanoma recurrence or death by 42%. Survival data are not yet mature.
Latest
Westlake Team Says Its Pinal AI Designs Working Proteins From Text
A Westlake University team says in Nature that its 16-billion-parameter Pinal model turned text prompts into proteins that worked in four lab tests.
Microsoft Diagnostic AI Scored 83% on Past Cases, Science Paper Says
Microsoft's MAI-DxO diagnosed 83% of complex past cases against 36% for doctors in a Science benchmark study. No product, approval or date is announced.
Hugging Face Releases Carbon-X, a 14.8B Open Model That Reads DNA
Hugging Face's open 14.8B Carbon-X model answers questions about raw DNA in English. It says it nears GPT-6.1 Sol but is not clinically validated.
Interpol-Led Africa Crackdown Nets 1,462 Arrests and Recovers $105m
Police in 21 countries arrested 1,462 suspects and recovered more than $105m in Interpol's Operation Serengeti III, which ran from June to August.
Xaira Says Its X-Scientist AI Matched Human Scientists at Picking Gene Targets
Xaira has unveiled X-Scientist, an agentic AI platform for drug discovery. Its lab test hit rate matched human curation, which it calls initial evidence.
UW and NVIDIA Say Open RFD4-Proteina Designs Proteins Up to 10 Times Faster
UW's Institute for Protein Design and NVIDIA have released RFD4-Proteina, an open model they say is 5-10x better on benchmarks. No paper is cited yet.
OpenAI Says Its GPT-Rosalind Agents Mined a Mouse-Brain Atlas in 32 Minutes
OpenAI, PerturbAI and Scripps say 1,946 GPT-Rosalind agents turned a mouse-brain CRISPR atlas into research leads in 32 minutes. Lab tests come next.
Sophont’s Holon-S1 Aims to Predict Tumour Gene Activity From Routine Slides
Sophont's Holon-S1 predicts spatial gene and pathway activity from routine H&E slides. It is for research use only, and results so far are the company's.
Radical Numerics Claims First AI-Designed Phage Given to a Patient
Radical Numerics says phages designed by its new Omnii-1 model were given to a patient with resistant E. coli. It has disclosed no outcome or peer review.
Anthropic Says Claude Designed Protein Binders Against Scorpion Neurotoxins
Anthropic says Claude designed protein binders against scorpion neurotoxins, with 17 of 211 tested designs meeting its criteria. It claims no antivenom.
Latest on TSN
Explore the TSN Atlas: Every topic we cover, mapped. Click a bubble to dive in.